Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Cerilliant
AstraZeneca
Accenture
Express Scripts
Moodys
McKesson
Federal Trade Commission
US Department of Justice

Generated: January 21, 2018

DrugPatentWatch Database Preview

Famotidine; ibuprofen - Generic Drug Details

« Back to Dashboard

What are the generic sources for famotidine; ibuprofen and what is the scope of famotidine; ibuprofen patent protection?

Famotidine; ibuprofen
is the generic ingredient in one branded drug marketed by Horizon Pharma and is included in one NDA. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Famotidine; ibuprofen has twenty-four patent family members in fourteen countries.

There are eighteen drug master file entries for famotidine; ibuprofen. One supplier is listed for this compound.
Summary for famotidine; ibuprofen
International Patents:24
US Patents:6
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 18
Suppliers / Packagers: 1
Clinical Trials: 563
Drug Prices:see low prices
DailyMed Link:famotidine; ibuprofen at DailyMed

US Patents and Regulatory Information for famotidine; ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Horizon Pharma DUEXIS famotidine; ibuprofen TABLET;ORAL 022519-001 Apr 23, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Horizon Pharma DUEXIS famotidine; ibuprofen TABLET;ORAL 022519-001 Apr 23, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Horizon Pharma DUEXIS famotidine; ibuprofen TABLET;ORAL 022519-001 Apr 23, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Horizon Pharma DUEXIS famotidine; ibuprofen TABLET;ORAL 022519-001 Apr 23, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Horizon Pharma DUEXIS famotidine; ibuprofen TABLET;ORAL 022519-001 Apr 23, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Horizon Pharma DUEXIS famotidine; ibuprofen TABLET;ORAL 022519-001 Apr 23, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for famotidine; ibuprofen

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Argus Health
Dow
Covington
Chubb
Daiichi Sankyo
AstraZeneca
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot